U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.7617+1G>C AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jul 23, 2019
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000235926.4

Allele description [Variation Report for NM_000059.4(BRCA2):c.7617+1G>C]

NM_000059.4(BRCA2):c.7617+1G>C

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.7617+1G>C
HGVS:
  • NC_000013.11:g.32356610G>C
  • NG_012772.3:g.46131G>C
  • NM_000059.4:c.7617+1G>CMANE SELECT
  • NM_001406719.1:c.7521+1G>C
  • NM_001406720.1:c.7617+1G>C
  • NM_001406721.1:c.2685+1G>C
  • NM_001406722.1:c.1200+1G>C
  • LRG_293t1:c.7617+1G>C
  • LRG_293:g.46131G>C
  • NC_000013.10:g.32930747G>C
  • NM_000059.3:c.7617+1G>C
Links:
dbSNP: rs397507922
NCBI 1000 Genomes Browser:
rs397507922
Molecular consequence:
  • NM_000059.4:c.7617+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406719.1:c.7521+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406720.1:c.7617+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406721.1:c.2685+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406722.1:c.1200+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000293723GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Dec 16, 2015)
germlineclinical testing

Citation Link,

SCV001133909Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Pathogenic
(Jul 23, 2019)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]
PMID:
26467025
PMCID:
PMC4737317

Details of each submission

From GeneDx, SCV000293723.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is denoted BRCA2 c.7617+1G>C or IVS15+1G>C and consists of a G>C nucleotide substitution at the +1 position of intron 15 of the BRCA2 gene. Using alternate nomenclature, this variant would be defined as BRCA2 7845+1G>C. This variant destroys a canonical splice donor site and is predicted to cause abnormal gene splicing, leading to either an abnormal message that is subject to nonsense-mediated mRNA decay or to an abnormal protein product. This variant has not, to our knowledge, been published in the literature. However, c.7617+1G>A and c.7617+1G>T have both been observed in individuals with familial breast and ovarian cancer and found to cause exon 15 skipping when functionally interrogated (van der Hout 2006, Thomassen 2011, Houdayer 2012, de Garibay 2014). Based on the current evidence, we consider BRCA2 c.7617+1G>C to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV001133909.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The BRCA2 c.7617+1G>C variant disrupts a canonical splice-donor site and interferes with normal BRCA2 mRNA splicing. This variant has not been reported in individuals with BRCA2-related conditions in the published literature. Based on the available information, this variant is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024